Literature DB >> 25435203

Securing the future of drug discovery for central nervous system disorders.

Peter Høngaard Andersen1, Richard Moscicki, Barbara Sahakian, Rémi Quirion, Ranga Krishnan, Tim Race, Anthony Phillips.   

Abstract

Innovative partnerships among researchers, patients, regulators, payors and industry are needed to reinvigorate drug discovery for central nervous system disorders. Here, we summarize plans of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) to achieve this goal.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25435203     DOI： 10.1038/nrd4489

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  1 in total

1.  A proposal for an updated neuropsychopharmacological nomenclature.

Authors:  Joseph Zohar; David J Nutt; David J Kupfer; Hans-Jurgen Moller; Shigeto Yamawaki; Michael Spedding; Stephen M Stahl
Journal:  Eur Neuropsychopharmacol       Date:  2013-09-18       Impact factor: 4.600
  1 in total
  2 in total

Review 1.  Annual Research Review: The contributions of the RDoC research framework on understanding the neurodevelopmental origins, progression and treatment of mental illnesses.

Authors:  Jennifer Pacheco; Marjorie A Garvey; Christopher S Sarampote; Elan D Cohen; Eric R Murphy; Stacia R Friedman-Hill
Journal:  J Child Psychol Psychiatry       Date:  2022-01-03       Impact factor: 8.265

2.  Quantum Artificial Neural Network Approach to Derive a Highly Predictive 3D-QSAR Model for Blood-Brain Barrier Passage.

Authors:  Taeho Kim; Byoung Hoon You; Songhee Han; Ho Chul Shin; Kee-Choo Chung; Hwangseo Park
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.